Kairos Pharma, Ltd. (KAPA) Stock price, Description, News & Info

#Thinksabio latest news

Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025